Amendment to SGD-1006 Commercial Supply Agreement Between SAFC, Inc. and Seattle Genetics, Inc.

Contract Categories: Business Operations › Supply Agreements
Summary

SAFC, Inc. and Seattle Genetics, Inc. have amended their existing supply agreement for the manufacturing of SGD-1006. Due to a new safety classification requiring stricter manufacturing controls, the cost to produce SGD-1006 has increased. This amendment updates the pricing schedule to reflect the additional time, materials, and labor needed for compliance. Both parties have agreed to the revised prices, which are effective as of the date of the amendment.

Read More Arrow
EX-10.17 2 d481013dex1017.htm EX-10.17 EX-10.17

Exhibit 10.17

[*] = Certain confidential information contained in this document, marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended.

Inspiring Science

Amendment to SGD-1006

Commercial Supply Agreement executed on 1 December 2010.

[*] Manufacturing Controls Price Increase

27 August 2013

Vaughn Himes

VP, Manufacturing

21823- 30th Drive S.E.

Bothell, WA 98021

Dear Vaughn:

Based on the recent Safebridge assessment of SGD-1006 and SGD-1010 occupation exposure level (OEL), a [*]classification has been applied to these molecules. This change in classification will require additional manufacturing containment and precautions for these [*].

This letter serves to amend the SGD-1006 pricing outlined in the supply agreement executed on 1 December 2010. The purpose of this costing revision is to capture the additional time and materials required to manufacture SGD-1006 [*].

[*] implementation will require extended suite time, additional materials, and FTEs. It is estimated that the implementation will result in a cost increase of [*]. Based on this assessment Seattle Genetics have agreed to increase payment for the [*]. The revised price per gram is outlined in the table below:

Revised SGD-1006 Pricing Schedule:

 

SG6 Quantity (g)   Current Price ($)/g   Batch Cost Increase   Revised Cost/g
[*]   [*]   [*]   [*]

[*]

Inspiring Science

IN WITNESS WHEREOF, the parties have executed this Amendment, effective as of the Amendment Effective Date.

Agreed and Accepted:

 

SAFC, Inc.     Seattle Genetics, Inc.
By:  

/s/ Gills Cotter

     By:  

/s/ Clay B. Siegall

Name:  

Gills Cotter

     Name:  

Clay B. Siegall

Title:  

President

     Title:  

President and CEO

Date:  

December 15, 2014

     Date:  

January 20, 2014